Skip to main content
Advertisement
Advertisement

SLN

SLN logo

Silence Therapeutics Plc - ADR

9.86
USD
Sponsored
+0.34
+3.57%
Oct 09, 15:59 UTC -4
Closed
exchange

After-Market

9.67

-0.19
-1.97%

SLN Earnings Reports

Positive Surprise Ratio

No Data Available for SLN

0%

Next Report

Date of Next Report
Nov 05, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/
--
Implied change from Q2 26 (Revenue/ EPS)
--
/
--
Implied change from Q3 25 (Revenue/ EPS)
--
/
--

Silence Therapeutics Plc - ADR earnings per share and revenue

On Aug 10, 2026, SLN reported earnings of -0.26 USD per share (EPS) for Q2 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference. The market reacted with a +29.12% price change (close before vs. close after earnings).
Looking ahead to Q3 26, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
NanoViricides Inc.
Report Date
Sep 28, 2026 For Q4 26
Estimate
-$0.10
Actual
-$0.10
Surprise
+1.96%
FAQ
For Q2 2026, Silence Therapeutics Plc - ADR reported EPS of -$0.26, missing estimates by --, and revenue of $0.00, -- -- expectations.
The stock price moved up 29.12%, changed from $11.95 before the earnings release to $15.43 the day after.
The next earning report is scheduled for Nov 05, 2026.
Based on -- analysts, Silence Therapeutics Plc - ADR is expected to report EPS of -- and revenue of -- for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement